Resistell AG
Resistell is dedicated to combating antimicrobial resistance by providing the world's fastest antibiotic susceptibility testing platform. Their innovative nanomotion technology platform delivers results in just 1 hour, enabling healthcare providers to make informed treatment decisions quickly. The company focuses on developing growth-independent, rapid diagnostic solutions that can analyze multiple drugs simultaneously, improving patient care and addressing the global challenge of antibiotic resistance.
Industries
Nr. of Employees
small (1-50)
Products
Ultra-rapid nanomotion AST platform (Phenotech Multistar)
A modular, high-throughput diagnostic platform that measures nanoscale cellular motion to provide antibiotic susceptibility results in approximately 1 hour; includes sensor hardware and classification software.
Ultra-rapid nanomotion AST platform (Phenotech Multistar)
A modular, high-throughput diagnostic platform that measures nanoscale cellular motion to provide antibiotic susceptibility results in approximately 1 hour; includes sensor hardware and classification software.
Services
Research nanomotion measurement service / platform
Research-oriented device and workflows to measure cellular nanomotion for exploratory assays, adaptable media/drug exchange and kit-based sample preparation for diverse microbiological and cellular applications.
Research nanomotion measurement service / platform
Research-oriented device and workflows to measure cellular nanomotion for exploratory assays, adaptable media/drug exchange and kit-based sample preparation for diverse microbiological and cellular applications.
Expertise Areas
- Rapid phenotypic antibiotic susceptibility testing
- Nanomechanical sensing and sensor development
- Machine learning for diagnostic classification
- Real-time signal acquisition and processing
Key Technologies
- Nanomechanical cantilever sensors
- Nanomotion detection
- AFM-based nanomechanical sensing
- Machine learning classification